A Prescription Drug User Fee Act target date of February 1, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--IP Infusion, a leading provider of intelligent network software for telecom and data communications services, announced that the company is working with the ...

Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help ...

For the fourth time already this month, the FDA has issued a notice formally bestowing a Class I label—denoting a heightened risk of serious injury or death—upon a recall of yet another drug delivery ...

On Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an investigational apomorphine infusion device under FDA review for the continuous treatment of motor ...

Supernus Pharmaceuticals (NASDAQ:SUPN) shares dipped ~11% premarket on Monday after the U.S. drug regulator rejected its experimental apomorphine infusion device for the continuous treatment of motor ...

Backed by founder capital and execution-focused leadership, the acquisition marks the commercial relaunch of the RxActuator Mini-Infuser ®, a validated, commercial-stage platform positioned at the ...

A Utah-based healthcare startup named Orion Innovations has released two studies this month demonstrating that its product helps nurses access medication lines faster and with less mental effort than ...

Sure, we'd all love a day at the spa getting essential-oil massages, dipping into hot and cold pools, and having a facialist whip those cheekbones into shape. But that's not a day-to-day reality for ...